FOCUS: ONCOLOGY
Promising signs for mRNA cancer vaccines
Messenger RNA, or mRNA, which had generated excitement in the cancer research community long before it became popularly associated with the Covid vaccine, is now offering glimmers of hope, with a number of successes in early-stage trials involving patients with pancreatic cancer. The key development, writes MedicalBrief, comes on the heels of other encouraging news about an experimental drug for pancreatic cancer.
Scientists are optimistic after a small group of cancer patients has shown strong immune response to an mRNA-based...

